Section 6: Education and Research

6ER-020

The occurrence of fluid overload in critically ill patients: is there a need for fluid stewardship?

6ER-029

Game-based training: play instead of reading boring procedures!

6ER-024

POTENTIALLY DRUG-RELATED PROBLEMS IN A POLYMEDICATED POPULATION

6ER-022

PHARMACOLOGICAL FACTORS RELATED TO HOSPITAL ADMISSIONS IN POLYMEDICATED ELDERLY PATIENS

6ER-017

PREVENTION OF EXTRAVASATION BY THE LOCAL APPLICATION OF HYBRID AEROGEL MICROPARTICLES AS DRUG DELIVERY SYSTEMS FOR CERVICAL CANCER CHEMOTHERAPY

6ER-015

MUTATIONS IN THE FACTOR VIII GENE IN OUR HAEMOPHILIA A POPULATION

6ER-005

REDUCING INVASIVE DEVICE-RELATED BLOODSTREAM INFECTIONS: A CHALLENGE FOR THE PREVENTION OF HEALTH-CARE ASSOCIATED INFECTIONS

6ER-027​

BLOOD CYTOKINE EVALUATION IN PATIENTS WITH INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION

6ER-028

MARKET EXCLUSIVITY EXPIRY HAS LIMITED EFFECT ON PRICES OF BRAND-NAME ORPHAN DRUGS

6ER-023

STUDY OF THE USE OF CEFTAZIDIMA-AVIBACTAM IN A THIRDLEVEL UNIVERSITY HOSPITAL

6ER-019

DETERMINATION OF DOXORUBICIN FROM THE EFLUATE OF CELLS USING THE DRUGLOG® SYSTEM

6ER-027​

BLOOD CYTOKINE EVALUATION IN PATIENTS WITH INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION

6ER-026

EFFECTIVENESS AND SAFETY OF APREMILAST IN A THIRD-LEVEL HOSPITAL

6ER-025

Real-life use of remdesivir in hospitalized COVID-19 patients with severe pneumonia: an observational study from an Italian University Hospital

6ER-021

EVALUATION OF COVID MORTALITY DURING HOSPITAL ADMISSION IN PATIENTS RECEIVING ONCOLOGIC TREATMENT

Pages